- Lobbying
- Joe AND O'Neill
Lobbying Arrangements Results for 'Joe O'neill'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Financial regulatory reform proposals FY24 appropriations Monitor trade-related legislation and regulation Issues related to international trade negotiations International capital standards for ins... |
Liberty Mutual Group
|
PUBLIC STRATEGIES WASHINGTON, INC. | |||
Details Financial reform implementation Comprehensive tax reform proposals Trade-related activities Cybersecurity-related activity FY2018 Appropriations Issues and policies related to the retail workforce |
RILA
|
PUBLIC STRATEGIES WASHINGTON, INC. | |||
Details Trade-related activities Monitor tax legislation Implementation of the Inflation Reduction Act FY24 Appropriations Regulations and legislation pertaining to freight rail transportation Ongoing moni... |
Grand Trunk Corporation
|
PUBLIC STRATEGIES WASHINGTON, INC. | |||
Details Aircraft operations, maintenance, and safety issues FAA reauthorization Proposals related to family seating on aircraft FY24 Appropriations Proposed legislation on sustainable aviation fuel tax cre... |
SOUTHWEST AIRLINES
|
PUBLIC STRATEGIES WASHINGTON, INC. | |||
Details General healthcare and public health, Diabetic eye screenings. Contact lens legislation.Issues related to COVID-19 stimulus legislation. |
American Optometric Association
|
Farragut Partners LLP | |||
Details Issues related to net neutrality |
CTIA-The Wireless Association
|
Farragut Partners LLP | |||
Details Implementation of the Inflation Reduction Act Energy reform proposals (H.R. 1) Offshore wind proposals Permitting reform proposals Monitor international trade and tariff activity, including UFLPA i... |
RWE Renewables Americas, LLC (formerly known as E. ON North America)
|
PUBLIC STRATEGIES WASHINGTON, INC. | |||
Details Medicare Part B and FDA. Cancer Payment Reform Legislation S. 462. Issues related to the 340B Drug discount program.Issues related to the part D donut hole. Medicare Part B and FDA. Cancer Payment ... |
AstraZeneca Pharmaceuticals LP
|
Farragut Partners LLP | |||
Details Issues pertaining to data security and privacy |
21st Century Privacy Coalition
|
Farragut Partners LLP | |||
Details Implementation of Family Smoking Protection and Tobacco Control Act of 2009 and FDA Tobacco Product Deeming proposed Rule. Legislation pertaining to flavor bans. |
Altria Client Services LLC
|
Farragut Partners LLP | |||
Details H.R.658, FAA Reauthorization and Reform Act of 2011. Issues relating to the rental car industry; tax issues including estate taxes; vicarious liability. |
Enterprise Holdings
|
Ogilvy Government Relations | |||
Details Work on issues related to solar energy policy and appropriations for perovskytes. |
Swift Solar Inc
|
Farragut Partners LLP | |||
Details Work related to derivative contract market related to sports betting |
RSBIX Co
|
Farragut Partners LLP | |||
Details Issues related to U.S. investment in Colombia. S.1094, Strengthening America's Schools Act of 2013; H.R.5, Student Success Act; issues related to Elementary and Secondary Education Act (ESEA) reaut... |
Rosetta Stone
|
Ogilvy Government Relations | |||
Details Crime, criminal justice, judiciary, work related to rated to the equal act (S.79) |
Families Against Mandatory Minimums
|
Farragut Partners LLP | |||
Details Issues related to the enhancement of the AbilityOne Program, disability policy, and federal procurement policy. |
NISH
|
Ogilvy Government Relations | |||
Details Issues related to digital health. |
Proteus Digital Health, Inc.
|
Farragut Partners LLP | |||
Details Issues relating to infrastructure |
SC3 International LLC
|
Farragut Partners LLP | |||
Details Covid legislation relating to long hauler studies |
Trio Health Regulatory Advisory Group, LLC
|
Farragut Partners LLP | |||
Details Discussions related to the reauthorization of the National Flood Insurance Program. Discussions related to cybersecurity. H.R.5381, GRATER Act of 2018; credit risk transfer. |
National Flood Services
|
Ogilvy Government Relations | |||
Details Consultation regarding energy projects |
RTW USA LLC
|
Farragut Partners LLP | |||
Details H.R.2810/S.1519, National Defense Authorization Act for Fiscal Year 2018 (P.L.115-91); S.1405, Federal Aviation Administration Reauthorization Act of 2017; H.R.2997, 21st Century AIRR Act; issues r... |
Potters Industries Inc.
|
Ogilvy Government Relations | |||
Details Issues related to H.R.3186/S.1706, Smuggled Tobacco Prevention Act of 2011 (STOP Act), the implementation of the PACT Act and the implementation of the Children's Health Insurance Program Reauthori... |
Seneca Nation of Indians
|
Ogilvy Government Relations | |||
Details Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation |
Heron Therapeutics, Inc.
|
Farragut Partners LLP | |||
Details Monitoring electrification issues in Congress |
Omega Flex
|
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. Issues related to ambulatory surgery centers. Opioid and prescription drug monitoring programs. U.S. S... |
American Society of Interventional Pain Physicians
|
Farragut Partners LLP | |||
Details Issues relating to the coverage of treatments for iron deficiency anemia. |
AMAG Pharmaceuticals, Inc.
|
Farragut Partners LLP | |||
Details Issues related to exon 20 cancer mutation. Issues related to FDA remote foreign site inspections |
Spectrum Pharmaceuticals, Inc
|
Farragut Partners LLP | |||
Details Issues Related to a COVID-19 Vaccine. Monitoring Vaccine legislation. Drug pricing. |
Novavax, Inc.
|
Farragut Partners LLP | |||
Details Issues relating to the coverage of treatments for iron deficiency anemia |
Daiichi Sankyo Inc
|
Farragut Partners LLP | |||
Details Copyright, communications and consumer protection |
AT&T Services, Inc.
|
Farragut Partners LLP | |||
Details General Healthcare issues, drug pricing legislation and issues related to chemotherapy Induced Neutropenia |
BeyondSpring Inc.
|
Farragut Partners LLP | |||
Details Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development. 21st Century Cures 2.0 |
Edwards Lifesciences, LLC
|
Farragut Partners LLP | |||
Details Issues related to the production of US based manufacturing of medical grade face masks |
Sanctuary Systems
|
Farragut Partners LLP | |||
Details Issues related to insurance market stabilization. Drug pricing reform. Surprise medical bill legislation. Issues related to COVID-19 stimulus legislation. Issues related to insurance market stabili... |
Blue Cross Blue Shield Association
|
Farragut Partners LLP | |||
Details Issues regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Drug Pricing Proposals. CMMI Guardrails. Issues related to drug pricing (IPI, Part B r... |
Genentech
|
Farragut Partners LLP | |||
Details lobbying activities specific to wireless policy on consumer protection and privacy issues in the House and Senate Commerce and Judiciary Committees; general lobbying spectrum related issues, includ... |
T-Mobile Association
|
Farragut Partners LLP | |||
Details Net Neutrality. Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues Privacy issues relating to the gathering, retention, and use of online information. |
Comcast Corporation
|
Farragut Partners LLP | |||
Details Legislation related to rewriting the Telecommunications act of 1934. Privacy issues Legislation related to autonomous issues and legislation related to automotive safety |
Cox Enterprises, Inc
|
Farragut Partners LLP | |||
Details Issues affecting the regulation of greenhouse gas emissions from power plants and other air and solid waste issues affecting power plant operations. Issues affecting federal regulation of electrici... |
Southern Company
|
Farragut Partners LLP | |||
Details Issues affecting the telecommunications industry including spectrum auction authority and pipeline, net neutrality, cybersecurity, privacy, robocalls, broadband mapping, deployment of broadband inc... |
Verizon Communications, Inc. and various subsidiaries
|
OGR (formerly known as Ogilvy Government Relations) | |||
Details Issues related to the implementation of the Patient Protection and Affordable Care Act (P.L.111-148), the pharmaceutical industry, diabetes care and mental health. Issues related to Medicare Part D... |
Takeda Pharmaceuticals America, Inc.
|
Ogilvy Government Relations | |||
Details Issues pertaining to ASC reimbursement/payment policy Issues related to implementation of surprise medical billing |
Ambulatory Surgery Center Association
|
Farragut Partners LLP | |||
Details Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney ad... |
Johnson & Johnson Services, Inc.
|
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmac... |
OneOncology Inc.
|
Farragut Partners LLP | |||
Details H.R.2529/S.1368, Restoring Access to Medication Act. Issues related to insuring access to over-the-counter drugs and Flexible Spending Accounts/Health Savings Accounts. S.3376, PACT Act; issues re... |
Consumer Healthcare Products Association
|
Ogilvy Government Relations | |||
Details Issues related to the definition of biomass. |
Arizona Chemical
|
Ogilvy Government Relations | |||
Details Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally. Issues ... |
Pharmaceutical Research and Manufacturers of America
|
PUBLIC STRATEGIES WASHINGTON, INC. | |||
Details Issues related to coverage of peripheral nerve stimulation |
SPR Therapeutics
|
Farragut Partners LLP | |||
Details general representation related to the power grid, energy efficiency and climate change |
DTE Energy
|
Farragut Partners LLP |